Din, S;
Kent, A;
Pollok, RC;
Meade, S;
Kennedy, NA;
Arnott, I;
Beattie, RM;
Chua, F;
Cooney, R;
Dart, RJ;
et al.
Din, S; Kent, A; Pollok, RC; Meade, S; Kennedy, NA; Arnott, I; Beattie, RM; Chua, F; Cooney, R; Dart, RJ; Galloway, J; Gaya, DR; Ghosh, S; Griffiths, M; Hancock, L; Hansen, R; Hart, A; Lamb, CA; Lees, CW; Limdi, JK; Lindsay, JO; Patel, K; Powell, N; Murray, CD; Probert, C; Raine, T; Selinger, C; Sebastian, S; Smith, PJ; Tozer, P; Ustianowski, A; Younge, L; Samaan, MA; Irving, PM
(2020)
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel.
Gut, 69 (10).
pp. 1769-1777.
ISSN 1468-3288
https://doi.org/10.1136/gutjnl-2020-321927
SGUL Authors: Pollok, Richard Charles G
Abstract
Objective Management of acute severe UC (ASUC) during the novel COVID-19 pandemic presents significant dilemmas. We aimed to provide COVID-19-specific guidance using current British Society of Gastroenterology (BSG) guidelines as a reference point.
Design We convened a RAND appropriateness panel comprising 14 gastroenterologists and an IBD nurse consultant supplemented by surgical and COVID-19 experts. Panellists rated the appropriateness of interventions for ASUC in the context of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Median scores and disagreement index (DI) were calculated. Results were discussed at a moderated meeting prior to a second survey.
Results Panellists recommended that patients with ASUC should be isolated throughout their hospital stay and should have a SARS-CoV-2 swab performed on admission. Patients with a positive swab should be discussed with COVID-19 specialists. As per BSG guidance, intravenous hydrocortisone was considered appropriate as initial management; only in patients with COVID-19 pneumonia was its use deemed uncertain. In patients requiring rescue therapy, infliximab with continuing steroids was recommended. Delaying colectomy because of COVID-19 was deemed inappropriate. Steroid tapering as per BSG guidance was deemed appropriate for all patients apart from those with COVID-19 pneumonia in whom a 4–6 week taper was preferred. Post-ASUC maintenance therapy was dependent on SARS-CoV-2 status but, in general, biologics were more likely to be deemed appropriate than azathioprine or tofacitinib. Panellists deemed prophylactic anticoagulation postdischarge to be appropriate in patients with a positive SARS-CoV-2 swab.
Conclusion We have suggested COVID-19-specific adaptations to the BSG ASUC guideline using a RAND panel.
Item Type: |
Article
|
Additional Information: |
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
Keywords: |
IBD clinical, clinical decision making, ulcerative colitis, 1103 Clinical Sciences, 1114 Paediatrics and Reproductive Medicine, Gastroenterology & Hepatology |
SGUL Research Institute / Research Centre: |
Academic Structure > Infection and Immunity Research Institute (INII) |
Journal or Publication Title: |
Gut |
ISSN: |
1468-3288 |
Language: |
eng |
Dates: |
Date | Event |
---|
7 September 2020 | Published | 8 June 2020 | Published Online | 26 May 2020 | Accepted |
|
Publisher License: |
Creative Commons: Attribution 4.0 |
Projects: |
|
PubMed ID: |
32513653 |
|
Go to PubMed abstract |
URI: |
https://openaccess.sgul.ac.uk/id/eprint/112004 |
Publisher's version: |
https://doi.org/10.1136/gutjnl-2020-321927 |
Statistics
Item downloaded times since 25 Jun 2020.
Actions (login required)
|
Edit Item |